Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment
- PMID: 24789109
- DOI: 10.1007/s11046-014-9749-1
Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment
Abstract
Candidiasis is the most common opportunistic yeast infection. Candida species and other microorganisms are involved in this complicated fungal infection, but Candida albicans continues to be the most prevalent. In the past two decades, it has been observed an abnormal overgrowth in the gastrointestinal, urinary and respiratory tracts, not only in immunocompromised patients, but also related to nosocomial infections and even in healthy individuals. There is a widely variety of causal factors that contribute to yeast infection which means that candidiasis is a good example of a multifactorial syndrome. Due to rapid increase in the incidence in these infections, this is the subject of numerous studies. Recently, the focus of attention is the treatment and, above all, the prevention of those complications. The diagnosis of candidiasis could become quite complicated. Prevention is the most effective "treatment," much more than eradication of the yeast with antifungal agents. There are several aspects to consider in the daily routine that can provide a strength protection. However, a therapeutic approach is necessary when the infection is established, and therefore, other alternatives should be explored. This review provides an overview on predisposition factors, prevention and diagnosis of candidiasis, highlighting alternative approaches for candidiasis treatment.
Similar articles
-
Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control - An update.Microb Pathog. 2018 Apr;117:128-138. doi: 10.1016/j.micpath.2018.02.028. Epub 2018 Feb 16. Microb Pathog. 2018. PMID: 29454824 Review.
-
Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents.Biomed Res Int. 2013;2013:204237. doi: 10.1155/2013/204237. Epub 2013 Jun 26. Biomed Res Int. 2013. PMID: 23878798 Free PMC article. Review.
-
Candida albicans targets that potentially synergize with fluconazole.Crit Rev Microbiol. 2021 May;47(3):323-337. doi: 10.1080/1040841X.2021.1884641. Epub 2021 Feb 15. Crit Rev Microbiol. 2021. PMID: 33587857 Review.
-
Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.Med Mycol. 2017 Aug 1;55(6):624-634. doi: 10.1093/mmy/myw126. Med Mycol. 2017. PMID: 27915303
-
Predisposing factors endorsing Candida infections.Infez Med. 2015 Sep;23(3):211-23. Infez Med. 2015. PMID: 26397289 Review.
Cited by
-
Health of Saudi Women in the Post-Pandemic Era: Candidiasis Incidence and Post COVID-19 and COVID-19-Vaccination.Int J Womens Health. 2024 Oct 13;16:1687-1697. doi: 10.2147/IJWH.S472953. eCollection 2024. Int J Womens Health. 2024. PMID: 39421715 Free PMC article.
-
Cryo-EM structures of Candida albicans Cdr1 reveal azole-substrate recognition and inhibitor blocking mechanisms.Nat Commun. 2024 Sep 6;15(1):7722. doi: 10.1038/s41467-024-52107-w. Nat Commun. 2024. PMID: 39242571 Free PMC article.
-
Multiple brain abscesses in a neonate: a rare case report along with review of literature.Ann Med Surg (Lond). 2024 May 17;86(8):4793-4798. doi: 10.1097/MS9.0000000000002155. eCollection 2024 Aug. Ann Med Surg (Lond). 2024. PMID: 39118725 Free PMC article.
-
Quantification methods of Candida albicans are independent irrespective of fungal morphology.Microb Cell. 2024 Jul 26;11:265-277. doi: 10.15698/mic2024.07.831. eCollection 2024. Microb Cell. 2024. PMID: 39081907 Free PMC article.
-
Synergic Effect of the Antimicrobial Peptide ToAP2 and Fluconazole on Candida albicans Biofilms.Int J Mol Sci. 2024 Jul 16;25(14):7769. doi: 10.3390/ijms25147769. Int J Mol Sci. 2024. PMID: 39063009 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
